Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study
Official Title: Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study Using a Target Trial Emulation Approach
Seoul National University Bundang Hospital
360 participants
Jan 22, 2026
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the clinical effectiveness of the oXiris® hemofilter in patients with septic shock and acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). While some studies suggest that oXiris® may improve hemodynamic stability by removing endotoxins and cytokines, its impact on survival remains inconsistent.To provide more reliable causal evidence, this multicenter retrospective cohort study utilizes a Target Trial Emulation (TTE) approach. The study will compare patients treated with the oXiris® filter to those treated with standard CRRT filters, focusing on in-hospital mortality and other clinical outcomes such as fluid balance and vasopressor requirements.
Eligibility
Inclusion Criteria3
- Adults aged 19 years or older.
- Admitted to the ICU with septic shock (Sepsis-3 criteria) between March 2021 and August 2025.
- Required Continuous Renal Replacement Therapy (CRRT) due to acute kidney injury (AKI).
Exclusion Criteria3
- Death or withdrawal of life-sustaining therapy within 48 hours of ICU admission.
- Patients with End-Stage Renal Disease (ESRD).
- Patients with missing critical covariates.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07539883